Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Autism and Developmental Disorders|January 13, 2016
Assessment of Cognitive Outcome Measures in Teenagers with 15q13.3 Microdeletion SyndromeEmeline Crutcher, May Ali, John Harrison, et al.
Psychiatry Research|February 15, 2005
The role of the striatal dopamine transporter in cognitive agingNina Erixon-Lindroth, Lars Farde, Tarja-Brita Robins Wahlin, et al.
Biological Psychiatry|April 12, 2015
Association of Long-Term Nicotine Abstinence With Normal Metabotropic Glutamate Receptor-5 BindingFunda Akkus, Valerie Treyer, Anass Johayem, et al.
Alzheimer'S Research & Therapy|April 29, 2015
Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer's diseaseMartin R Farlow, Niels Andreasen, Marie-Emmanuelle Riviere, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2012
Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomographyFunda Akkus, Simon M Ametamey, Valerie Treyer, et al.
Brain Structure & Function|June 28, 2014
Decrease of mGluR5 receptor density goes parallel with changes in enkephalin and substance P immunoreactivity in Huntington's disease: a preliminary investigation in the postmortem human brainBalázs Gulyás, Judit Sovago, Baltazar Gomez-Mancilla, et al.
The International Journal of Neuropsychopharmacology|May 17, 2014
Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorderFunda Akkus, Sylvia Terbeck, Simon M Ametamey, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b studyRik Vandenberghe, Marie-Emmanuelle Riviere, Angelika Caputo, et al.
Biological Psychiatry|September 11, 2012
Increased metabotropic glutamate receptor subtype 5 availability in human brain after one night without sleepKatharina Hefti, Sebastian C Holst, Judit Sovago, et al.
Nuclear Medicine Communications|July 8, 2005
Whole-body biodistribution, radiation dosimetry estimates for the PET norepinephrine transporter probe (S,S)-[18F]FMeNER-D2 in non-human primatesNicholas Seneca, Bengt Andree, Nils Sjoholm, et al.
Pageof 2